Pan-Cancer Analysis Revealed <i>SRSF9</i> as a New Biomarker for Prognosis and Immunotherapy.

J Oncol · 2022 · PMC8769850 · PMID 35069733

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In LIHC, SRSF9 was highly significant correlated with most immune checkpoint genes.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.